Deprenyl in the treatment of Parkinson's disease | 合法藥品大搜索

由 佳蓉鍾 著作 · 2009 — Selegiline（別名deprenyl）為一種單胺氧化酶抑制劑(monoamine oxidase inhibitor)，通常合併左多巴胺(L-dopa)一起治療帕金森氏症，但服用後會代謝成安非他命與甲基 ... Read More

Selegiline, also known as L-deprenyl and sold under the brand names Eldepryl and Emsam among others, is a medication which is used in the treatment of ... Read More

由 J Knoll 著作 · 1983 · 被引用 221 次 — Deprenyl inhibits MAO-B selectively in different animal species and in man. Its safety margin is remarkable. We were able to block MAO-B activity in the ... Read More

由 J Knoll 著作 · 1992 · 被引用 62 次 — Deprenyl (Selegiline, Jumex, Eldepryl, Movergan), a close structural relative to phenylethylamine (PEA), is a drug with a unique pharmacological spectrum. Read More

由 CW Olanow 著作 · 1996 · 被引用 31 次 — Deprenyl in the treatment of Parkinson's disease: clinical effects and speculations on mechanism of action ... J Neural Transm Suppl. 1996;48:75-84. doi: 10.1007/ ... Read More

由 P Vezina 著作 · 1992 · 被引用 38 次 — Deprenyl is a synthetic, selective inhibitor of the monoamine oxidase-B enzyme system. The mechanism of its beneficial effect in early and advanced ... Read More

由 J Knoll 著作 · 2000 · 被引用 57 次 — Deprenyl (Selegiline), the N-propargyl analogue of (-)methamphetamine, is the only drug in clinical case which, by enhancing the impulse propagation ... Read More

Therefore, early deprenyl therapy delays the requirement for antiparkinsonian medication, possibly by slowing progression of the disease. Publication types. Read More

由 WG Tatton 著作 · 1996 · 被引用 106 次 — (-)-Deprenyl reduces neuronal apoptosis and facilitates neuronal outgrowth by altering protein synthesis without inhibiting monoamine oxidase · Authors. Read More

由 J Knoll 著作 · 1992 · 被引用 48 次 — Deprenyl (selegiline, jumex, eldepryl, movergan) which is closely related to phenylethylamine (PEA) is a drug with a unique pharmacological spectrum. Read More